Close

antiviral

Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code–Level Social Vulnerability — United States, December 23, 2021–May 21, 2022

Summary What is already known about this topic? Lagevrio and Paxlovid are oral antiviral drugs effective at preventing hospitalization and death in patients with mild to moderate COVID-19 who are at risk for progression to severe disease. What is added by this report? During December 23, 2021–May 21, 2022, 1,076,762 […]

Read More

Tecovirimat, el antiviral más prometedor para el tratamiento de la viruela del mono

La ministra de Sanidad, Carolina Darias, anunció el pasado 25 de mayo en la rueda de prensa posterior al Consejo Interterritorial del Sistema Nacional de Salud (CISNS), la participación de España, junto al resto de Estados miembros de la Unión Europea, en la adquisición conjunta de Imvanex, la vacuna autorizada en julio de 2013 […]

Read More

Oral Antiviral Medications for COVID-19

Two new oral antiviral medications are available for treatment of COVID-19. Two new antiviral medications, ritonavir-boosted nirmatrelvir (Paxlovid, ie, nirmatrelvir-ritonavir) and molnupiravir (Lagevrio), are currently available in the US under emergency use authorization. These 2 drugs are authorized for treatment of patients with mild to moderate COVID-19 who are not […]

Read More

Nasal antiviral blocks SARS-CoV-2 infection in mice

SARS-CoV-2, the virus that causes COVID-19, has continuously mutated since it emerged in late 2019. This rapid evolution poses challenges for vaccines and treatments designed to target the virus. A booster shot is now needed to produce antibodies to fight off the Omicron variant of SARS-CoV-2. And several combinations of […]

Read More

Thousands more patients to access second ground-breaking antiviral

Thousands more vulnerable people are eligible to receive the UK’s second antiviral Paxlovid, which has been added to the PANORAMIC national study. Paxlovid reduced the risk of hospitalisation or death by 88% in clinical trials and is already available directly through the NHS to highest-risk patients The UK has procured […]

Read More

Molnupiravir: The Game-Changing Antiviral Pill for COVID-19?

Pharmaceutical company Merck applied on October 11 for FDA emergency use authorization for its oral antiviral COVID-19 drug, molnupiravir. In this Q&A, Carl Dieffenbach, PhD, director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, and Joshua Sharfstein, MD, talk about the development of the medication, how […]

Read More

Regen-cov: el primer tratamiento antiviral que demuestra salvar vidas de enfermos graves con covid

Un caro cóctel de anticuerpos ajenos evita una muerte por cada 17 pacientes tratados, según los resultados del mayor ensayo clínico del mundo. La humanidad desarrolló en tiempo récord vacunas para evitar la covid, pero acumula fracasos en la carrera para encontrar un tratamiento eficaz para las personas que ya tienen […]

Read More
Translate »